Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedAdded a site-wide funding notice about government lapse and operating status; updated version to v3.4.1 (replacing v3.4.0); To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check14 days agoChange DetectedThe page now includes a 'Show glossary' option, uses green/red highlights to indicate additions and deletions, and updates the revision tag to v3.4.0 while removing older items like No FEAR Act data and v3.3.4.SummaryDifference1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedVersion history now shows a new revision entry v3.3.4 and removes v3.3.3 from the history. This is a minor metadata update that does not affect current study details such as recruitment status or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.3.3 was added to the record history. The 'HHS Vulnerability Disclosure' link and the prior 'Revision: v3.3.2' entry were removed.SummaryDifference0.2%

- Check78 days agoChange DetectedA new revision v3.3.2 was added and an older revision v3.2.0 was removed from the Record History.SummaryDifference0.1%

- Check85 days agoChange DetectedA government funding status notice was removed from the page. This notice pertained to operating status and does not affect the study's data, recruitment, or results.SummaryDifference0.8%

Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.